Amedeo Smart

Free Medical Literature Service



Autoimmune Disorders

  Free Subscription

Articles published in
Acta Neurol Scand
    August 2022
  1. MAGALHAES JE, Sampaio-Rocha-Filho PA
    Reply: Neurological disease in pregnant females with COVID-19 may not only be attributable to SARS-CoV-2.
    Acta Neurol Scand. 2022;146:201-202.
    >> Share

    July 2022
  2. MAHAMUD Z, Burman J, Zelano J
    Temporal trends of epilepsy in multiple sclerosis.
    Acta Neurol Scand. 2022 Jul 18. doi: 10.1111/ane.13671.
    >> Share

  3. MACHADO A, Murley C, Hillert J, Alexanderson K, et al
    Self-employment, sickness absence, and disability pension in multiple sclerosis.
    Acta Neurol Scand. 2022 Jul 4. doi: 10.1111/ane.13664.
    >> Share

    June 2022
  4. HAYAT S, Asad A, Hasan I, Jahan I, et al
    Nucleotide oligomerization domain polymorphism confers no risk to Guillain-Barre syndrome.
    Acta Neurol Scand. 2022 Jun 2. doi: 10.1111/ane.13649.
    >> Share

    May 2022
  5. OZAKBAS S, Piri Cinar B, Baba C, Kosehasanogullari G, et al
    Self-injectable DMTs in relapsing MS: NEDA assessment at 10 years in a real-world cohort.
    Acta Neurol Scand. 2022;145:557-564.
    >> Share

    April 2022
  6. ZHAO YY, Wang HX, Wang M, Yuan B, et al
    Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis.
    Acta Neurol Scand. 2022;145:434-441.
    >> Share

  7. SUN Y, Ren G, Ren J, Shan W, et al
    The prognosis of late-onset anti-N-methyl-D-aspartate receptor encephalitis in China.
    Acta Neurol Scand. 2022;145:449-455.
    >> Share

  8. CABREIRA V, Dias L, Fernandes B, Aires A, et al
    Tocilizumab for severe refractory primary central nervous system vasculitis: A center experience.
    Acta Neurol Scand. 2022;145:479-483.
    >> Share

    March 2022
    Comment on comorbidities in older patients with myasthenia gravis.
    Acta Neurol Scand. 2022 Mar 20. doi: 10.1111/ane.13606.
    >> Share

    February 2022
  10. PARK JS, Eah KY, Park JM
    Epidemiological profile of myasthenia gravis in South Korea using the national health insurance database.
    Acta Neurol Scand. 2022 Feb 9. doi: 10.1111/ane.13596.
    >> Share

    Very late onset of myasthenia gravis. Comment: Comorbidities in older patients with myasthenia gravis.
    Acta Neurol Scand. 2022 Feb 7. doi: 10.1111/ane.13588.
    >> Share

    January 2022
  12. WELD-BLUNDELL IV, Grech L, Learmonth YC, Marck CH, et al
    Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review.
    Acta Neurol Scand. 2022 Jan 17. doi: 10.1111/ane.13574.
    >> Share

  13. SOBIESZCZUK E, Napiorkowski L, Szczudlik P, Kostera-Pruszczyk A, et al
    Myasthenia gravis-treatment and severity in nationwide cohort.
    Acta Neurol Scand. 2022 Jan 4. doi: 10.1111/ane.13576.
    >> Share

    Neurological side effects of SARS-CoV-2 vaccinations.
    Acta Neurol Scand. 2022;145:5-9.
    >> Share

    December 2021
  15. LAHOZ FERNANDEZ PE, Miranda Pereira J, Fonseca Risso I, Baleeiro Rodrigues Silva P, et al
    Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Acta Neurol Scand. 2021 Dec 29. doi: 10.1111/ane.13575.
    >> Share

    November 2021
  16. SMYRKE N, Dunn N, Murley C, Mason D, et al
    Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis.
    Acta Neurol Scand. 2021 Nov 24. doi: 10.1111/ane.13559.
    >> Share

  17. THEODORSDOTTIR A, Larsen PV, Nielsen HH, Illes Z, et al
    Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.
    Acta Neurol Scand. 2021 Nov 19. doi: 10.1111/ane.13554.
    >> Share

  18. CHAABAN L, Safwan N, Moussa H, El-Sammak S, et al
    Central vein sign: A putative diagnostic marker for multiple sclerosis.
    Acta Neurol Scand. 2021 Nov 18. doi: 10.1111/ane.13553.
    >> Share

  19. KLIMIEC-MOSKAL E, Quirke M, Leite MI
    Comorbidities in older patients with myasthenia gravis - Comparison between early- and late-onset disease.
    Acta Neurol Scand. 2021 Nov 8. doi: 10.1111/ane.13549.
    >> Share

  20. CONTRERAS JP, Salinas R, Vidal C, Hoffmeister L, et al
    Validation of Spanish version of 15-item myasthenia gravis quality-of-life questionnaire.
    Acta Neurol Scand. 2021;144:546-552.
    >> Share

    October 2021
  21. LANGESKOV-CHRISTENSEN M, Hvid LG, Jensen HB, Nielsen HH, et al
    Efficacy of high-intensity aerobic exercise on common multiple sclerosis symptoms.
    Acta Neurol Scand. 2021 Oct 22. doi: 10.1111/ane.13540.
    >> Share

    September 2021
  22. KAUR H, Sureshbabu S, Mittal GK, Joseph M, et al
    Catastrophic health expenditure in patients with Guillain Barre syndrome: Retrospective study.
    Acta Neurol Scand. 2021 Sep 1. doi: 10.1111/ane.13523.
    >> Share

    August 2021
  23. MARIC G, Pekmezovic T, Tamas O, Veselinovic N, et al
    Impact of comorbidities on the disability progression in multiple sclerosis.
    Acta Neurol Scand. 2021 Aug 20. doi: 10.1111/ane.13516.
    >> Share

  24. TELJAS C, Bostrom I, Marrie RA, Landtblom AM, et al
    Validating the diagnosis of multiple sclerosis using Swedish administrative data in Varmland County.
    Acta Neurol Scand. 2021 Aug 6. doi: 10.1111/ane.13514.
    >> Share

    July 2021
  25. JOHANSSON K, Wasling P, Axelsson M
    Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy.
    Acta Neurol Scand. 2021 Jul 19. doi: 10.1111/ane.13497.
    >> Share

    June 2021
  26. ZHUKOVSKY C, Herman S, Wiberg A, Cunningham JL, et al
    Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-beta treatment.
    Acta Neurol Scand. 2021;143:602-607.
    >> Share

    May 2021
  27. LANDTBLOM AM, Berntsson SG, Bostrom I, Iacobaeus E, et al
    Multiple sclerosis and COVID-19: The Swedish experience.
    Acta Neurol Scand. 2021 May 24. doi: 10.1111/ane.13453.
    >> Share

  28. TARAKCI E, Tarakci D, Hajebrahimi F, Budak M, et al
    Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis.
    Acta Neurol Scand. 2021 May 7. doi: 10.1111/ane.13448.
    >> Share

    April 2021
  29. FEASEL CD, Sandroff BM, Motl RW
    Aerobic reserve capacity in multiple sclerosis-Preliminary evidence.
    Acta Neurol Scand. 2021 Apr 29. doi: 10.1111/ane.13441.
    >> Share

  30. SAIED Z, Rachdi A, Thamlaoui S, Nabli F, et al
    Myasthenia gravis and COVID-19: A case series and comparison with literature.
    Acta Neurol Scand. 2021 Apr 29. doi: 10.1111/ane.13440.
    >> Share

    March 2021
  31. DONSKOV AO, Vinge L, Axelsen SM, Andersen H, et al
    Overactive bladder in patients with myasthenia gravis-A cross-sectional population-based study.
    Acta Neurol Scand. 2021 Mar 27. doi: 10.1111/ane.13419.
    >> Share

  32. KAVALIUNAS A, Danylaite Karrenbauer V, Hillert J
    Socioeconomic consequences of multiple sclerosis-A systematic literature review.
    Acta Neurol Scand. 2021 Mar 22. doi: 10.1111/ane.13411.
    >> Share

    February 2021
  33. OLSSON A, Gustavsen S, Gisselo Lauridsen K, Chenoufi Hasselbalch I, et al
    Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review.
    Acta Neurol Scand. 2021 Feb 16. doi: 10.1111/ane.13401.
    >> Share

    December 2020
  34. TEKEOGLU A, Yeldan I, Ozdincler AR, Saip S, et al
    The efficiency of mirror therapy on drop foot in Multiple Sclerosis Patients.
    Acta Neurol Scand. 2020 Dec 3. doi: 10.1111/ane.13385.
    >> Share

  35. RYLTOFT AK, Al-Zuhairy A, Sindrup SH, Andersen H, et al
    Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
    Acta Neurol Scand. 2020;142:637-640.
    >> Share

    November 2020
  36. NI G, Lin W, Cai X, Qin J, et al
    Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
    Acta Neurol Scand. 2020;142:460-465.
    >> Share

  37. BORGSTROM M, Tisell A, Link H, Wilhelm E, et al
    Retinal thinning and brain atrophy in early MS and CIS.
    Acta Neurol Scand. 2020;142:418-427.
    >> Share

    September 2020
  38. TRIPATHI M, St AR, Ihtisham K, Garg A, et al
    Metabolic scoring in Autoimmune Epilepsy-Should APE scores be modified?
    Acta Neurol Scand. 2020 Sep 16. doi: 10.1111/ane.13346.
    >> Share

  39. CHESHMAVAR M, Mirmosayyeb O, Badihian N, Badihian S, et al
    Rituximab and glatiramer-acetate in secondary-progressive multiple sclerosis: A randomized-clinical trial.
    Acta Neurol Scand. 2020 Sep 8. doi: 10.1111/ane.13344.
    >> Share

    August 2020
  40. CHEN J, Shang W, Chen Y, Li Y, et al
    Thymomatous Myasthenia Gravis: 10-year Experience of a Single Center.
    Acta Neurol Scand. 2020 Aug 6. doi: 10.1111/ane.13332.
    >> Share

  41. WONG VT, So H, Lam TT, Yip RM, et al
    Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
    Acta Neurol Scand. 2020 Aug 6. doi: 10.1111/ane.13331.
    >> Share

  42. JONS D, Zetterberg H, Malmestrom C, Bergstrom T, et al
    Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
    Acta Neurol Scand. 2020;142:161-168.
    >> Share

    July 2020
  43. WANDELL P, Fredrikson S, Carlsson AC, Li X, et al
    Multiple sclerosis among first- and second-generation immigrant groups in Sweden.
    Acta Neurol Scand. 2020 Jul 10. doi: 10.1111/ane.13314.
    >> Share

  44. VECCHIO D, Varrasi C, Virgilio E, Spagarino A, et al
    Cannabinoids in multiple sclerosis: A neurophysiological analysis.
    Acta Neurol Scand. 2020 Jul 6. doi: 10.1111/ane.13313.
    >> Share

    June 2020
  45. LAHDENPERA S, Soilu-Hanninen M, Kuusisto HM, Atula S, et al
    Medication adherence/persistence among patients with active multiple sclerosis in Finland.
    Acta Neurol Scand. 2020 Jun 19. doi: 10.1111/ane.13301.
    >> Share

  46. NING P, Yang B, Yang X, Zhao Q, et al
    A nomogram to predict mechanical ventilation in Guillain-Barre syndrome patients.
    Acta Neurol Scand. 2020 Jun 4. doi: 10.1111/ane.13294.
    >> Share

  47. PIRTTISALO AL, Soilu-Hanninen M, Sumelahti ML, Krokki O, et al
    Changes in multiple sclerosis epidemiology in Finland over five decades.
    Acta Neurol Scand. 2020 Jun 4. doi: 10.1111/ane.13295.
    >> Share

  48. NEPAL G, Shing YK, Yadav JK, Rehrig JH, et al
    Efficacy and safety of rituximab in autoimmune encephalitis: a meta-analysis.
    Acta Neurol Scand. 2020 Jun 2. doi: 10.1111/ane.13291.
    >> Share

    May 2020
  49. MAMOEI S, Hvid LG, Boye Jensen H, Zijdewind I, et al
    Neurophysiological impairments in multiple sclerosis - central and peripheral motor pathways.
    Acta Neurol Scand. 2020 May 31. doi: 10.1111/ane.13289.
    >> Share

  50. ZANONI M, Orlandi E, Rossetti G, Turatti M, et al
    Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Acta Neurol Scand. 2020 May 20. doi: 10.1111/ane.13288.
    >> Share

  51. ZHU F, Shan W, Lv R, Li Z, et al
    Clinical characteristics of GAD 65 associated autoimmune encephalitis.
    Acta Neurol Scand. 2020 May 16. doi: 10.1111/ane.13281.
    >> Share

  52. COSTA ARPIN E, Naveiro Soneira J, Lema Bouzas M, Quintela AG, et al
    Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
    Acta Neurol Scand. 2020 May 11. doi: 10.1111/ane.13265.
    >> Share

    April 2020
  53. CHOU CC, Huang MH, Lan WC, Kong SS, et al
    Prevalence and risk of thyroid diseases in myasthenia gravis.
    Acta Neurol Scand. 2020 Apr 23. doi: 10.1111/ane.13254.
    >> Share

    March 2020
  54. ZARGHAMI A, Nourmohammadi ST, Hojjati SMM
    Urbanization theory and socioeconomic changeover of multiple sclerosis in Iran.
    Acta Neurol Scand. 2020;141:256.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016